Drug Shortage Report for MYLAN-CELECOXIB
Report ID | 140 |
Drug Identification Number | 02399881 |
Brand name | MYLAN-CELECOXIB |
Common or Proper name | Celecoxib |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | CELECOXIB |
Strength(s) | 200MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 100 BT |
ATC code | M01AH |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-07-03 |
Actual start date | 2018-07-03 |
Estimated end date | Unknown |
Actual end date | 2018-07-03 |
Shortage status | Resolved |
Updated date | 2018-07-05 |
Company comments | Discontinued in ID 44830 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v16 | 2018-07-05 | French | Compare |
v15 | 2018-07-05 | English | Compare |
v14 | 2018-07-04 | English | Compare |
v13 | 2018-07-03 | French | Compare |
v12 | 2018-07-03 | English | Compare |
v11 | 2018-07-03 | English | Compare |
v10 | 2018-04-03 | French | Compare |
v9 | 2018-04-03 | English | Compare |
v8 | 2017-04-25 | French | Compare |
v7 | 2017-04-25 | English | Compare |
v6 | 2017-04-13 | French | Compare |
v5 | 2017-04-13 | English | Compare |
v4 | 2017-03-29 | French | Compare |
v3 | 2017-03-29 | English | Compare |
v2 | 2017-03-10 | French | Compare |
v1 | 2017-03-10 | English | Compare |
Showing 1 to 16 of 16